Prof. Dr. Ulrich Keller

Medical Degrees

• MD & Doctorate (Dr. med.) — Johannes Gutenberg University, Mainz, Germany
• Specialist Certification (Facharzt) in Internal Medicine — Klinikum rechts der Isar, TU Munich, 2006
• Subspecialty Certification in Haematology & Medical Oncology — Germany
• Habilitation & Adjunct Professorship (außerplanmäßiger Professor) — Technical University of Munich (2013)
• Full Professorship (W3) — Charité – Universitätsmedizin Berlin (2018)

Fellowships & Special Training

• Internal Medicine Specialist Training — Klinikum rechts der Isar, TU Munich
• Subspecialty training in Lymphoma, Multiple Myeloma and Stem-Cell Transplantation
• Translational research fellowships in molecular oncology / lymphomagenesis

Certifications & Accreditations

• Berlin State Medical Council — Registered Specialist
• Member, German Society of Haematology and Medical Oncology (DGHO)
• Member, European Hematology Association (EHA)
• Member, American Society of Hematology (ASH)
• Active member, German Cancer Consortium (DKTK) and Berlin Institute of Health (BIH)

Current Affiliation

• Director (Ärztlicher Direktor / Klinikdirektor), Medical Department with Focus on Hematology, Oncology and Cancer Immunology — Charité – Universitätsmedizin Berlin, Campus Benjamin Franklin (since 1 November 2018 – Present)
• Medical Director, CharitéCenter 14 (Tumor Medicine) — Charité Berlin (Present)
• Full Professor (W3) of Haematology & Oncology with focus on Lymphomas / Multiple Myeloma — Charité Berlin (Present)

Past Affiliations

• Klinikum rechts der Isar, Technical University of Munich, Germany — Senior Consultant (Leitender Oberarzt) and Deputy Director, III. Medizinische Klinik (Hematology, Oncology & Stem Cell Transplantation), 2012–2018 (~6 years)
• Klinikum rechts der Isar, TU Munich — Oberarzt and Adjunct Professor (außerplanmäßiger Professor), 2006–2013
• Johannes Gutenberg University, Mainz, Germany — Medical Studies and Doctoral Research

Academic & Research Roles

• Full Professor (W3) — Charité – Universitätsmedizin Berlin
• Principal Investigator — Keller Group, CBF (Lymphoma, Myeloma and AML research)
• DFG-funded research projects on MYC, N-MYC oncoproteins, haematopoiesis and CKS1
• Member — German Cancer Consortium (DKTK), Berlin Institute of Health (BIH)
• Active mentor — “Clinician Scientist” / “Medical Scientist” training programmes

Key Achievements

• Director of one of Germany’s largest haematology / oncology university clinics
• Internationally recognised translational research programme on lymphomas, myeloma and AML
• Medical Director of Charité’s Tumour Medicine Centre across three campuses
• Substantial contribution to clinical trials in DLBCL, multiple myeloma and Hodgkin lymphoma